In the News

Connect with us

Stay Informed.
Get the latest news and updates on MSK’s cancer care and research breakthroughs sent straight to your inbox with our e-newsletters.
Newsletter Sign Up
1877 News Items found
An MSK researcher at work in the lab
MSK Research Highlights, May 26, 2026

New MSK research provides structural insights into how cancer cells thwart targeted RAS therapies; uncovers promising combination therapies for a rare childhood brain tumor; uses organoids to provide important clues about what drives pancreatic cancer; takes aim at appendix cancer with new laboratory models; and a develops a new precision tool for targeting cancer's energy factory.
Dr. Shanu Modi speaks with a patient
In the Clinic
FDA Approves Trastuzumab Deruxtecan (T-DXd) for Early-Stage HER2-Positive Breast Cancer

The FDA has approved trastuzumab deruxtecan (T-DXd, Enhertu) for treating early-stage, HER2-positive breast cancer based in part on clinical research led by MSK breast medical oncologist Shanu Modi, MD.
Dr. Alison Schram
FDA Approves Zenocutuzumab for Cholangiocarcinoma Based on MSK-Led Trial

The FDA has approved zenocutuzumab (Bizengri®) for adults with advanced, unresectable, or metastatic cholangiocarcinoma driven by a molecular change called an NRG1 gene fusion, based on a trial led by an MSK investigator.
Riders on stationary bikes cheer and hold pompoms in a party-like atmosphere for Cycle for Survival
MSK Giving in 2025

In 2025, the MSK Giving community accelerated its commitment to redefine what’s possible in cancer care worldwide. Together, 348,000 donors contributed...
GSK Graduates and MSK Leadership pose on the stage
MSK’s 2026 Graduation Recognizes Today's Achievements and Tomorrow's Leaders

At Memorial Sloan Kettering Cancer Center’s 47th annual ceremony, graduating master's and PhD students were honored and award winners were recognized.
A doctor holds the hand of a patient, who is dressed in a hospital gown
Just Diagnosed With a Brain Tumor? What You Should Do Next

Learn what to do right after you've been diagnosed with brain cancer, from MSK experts who specialize in treating this kind of cancer.
micrograph of a T cell
Successfully Treated AML Patients May Hold the Key to New CAR T Cell Therapy

A team of researchers from MSK has developed a new type of CAR T cell therapy that shows promise against acute myeloid leukemia (AML) in preclinical models.
A hand points to brain images on a screen.
In the Clinic
Treating Cancer When It Spreads to the Brain

MSK doctors and scientists are leading the charge to find new and innovative ways to treat metastatic brain cancer.
Dr. Bobby Daly seen smiling with patient.
MSK Clinical Trials: Bringing the Promise of New Medicine to More Patients

Learn how MSK is making clinical trials more accessible through innovative new approaches that bring care to people's homes and make participating possible even for people who live far from MSK.
A liquid being pipetted into a well plate.
Meet the 2026 Graduates of the Gerstner Sloan Kettering Graduate School

Fifteen young scientists are poised to receive their PhD degrees from the Gerstner Sloan Kettering Graduate School of Biomedical Sciences. Their years of dedication and training will be recognized on May 13, 2026, as part of Memorial Sloan Kettering’s 47th annual academic convocation.